Skip to main content
Figure 2 | Allergy, Asthma & Clinical Immunology

Figure 2

From: Effect of allergen-specific immunotherapy with purified Alt a1 on AMP responsiveness, exhaled nitric oxide and exhaled breath condensate pH: a randomized double blind study

Figure 2

Individual values for exhaled nitric oxide (ENO) concentrations in the specific immunotherapy and placebo groups at baseline and after 6 and 12 months of treatment. Horizontal lines are geometric means. Changes in ENO levels were not significantly different between the SIT and placebo groups (P = 0.86 and P = 0.53 for changes at 6 and 12 months of treatment, respectively).

Back to article page